Brought to you by 
Basilea Pharmaceutica raises CHF205.8mm with IPO
02 Apr 2004
Executive Summary
Basilea Pharmaceutica Ltd. (develops antibacterial, antifungal, and dermatological therapeutics) raised CHF205.8mm ($161.2mm) with an IPO of 2.1mm shares priced at CHF98 on the Swiss SWX market. The company's proposed price range when it filed earlier this month was CHF90-115; it originally sought to raise CHF189-241.5mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Basilea Pharmaceutica raises CHF205.8mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice